|
SU389090A1
(ru)
|
1971-05-17 |
1973-07-05 |
Ташкентский государственный медицинский институт |
Библиотека
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
US5229272A
(en)
|
1989-04-25 |
1993-07-20 |
Igen, Inc. |
Catalytic antibody components
|
|
EP0184365B1
(en)
|
1984-12-04 |
1993-08-04 |
Eli Lilly And Company |
Improvements in the treatment of tumors in mammals
|
|
ZA859008B
(en)
|
1984-12-04 |
1987-07-29 |
Lilly Co Eli |
The treatment of tumors in mammals
|
|
DE3786834T2
(de)
|
1986-04-30 |
1994-03-03 |
Otsuka Pharma Co Ltd |
5-Fluoro-Uracil-Derivate.
|
|
US6702705B1
(en)
|
1988-05-04 |
2004-03-09 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
|
JPH04501253A
(ja)
|
1988-05-25 |
1992-03-05 |
リサーチ コーポレーシヨン テクノロジーズ インコーポレーテツド |
抗腫瘍剤として有用なホスホラミド
|
|
DE3834861A1
(de)
|
1988-10-13 |
1990-04-19 |
Basf Ag |
Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
|
|
DE3834860A1
(de)
|
1988-10-13 |
1990-04-19 |
Basf Ag |
Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
|
|
US6258360B1
(en)
|
1989-05-04 |
2001-07-10 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
|
US6060592A
(en)
|
1990-01-11 |
2000-05-09 |
Isis Pharmaceuticals, Inc. |
Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
|
|
US5401838A
(en)
|
1992-06-22 |
1995-03-28 |
Eli Lilly And Company |
Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
|
HU217779B
(hu)
|
1993-06-08 |
2000-04-28 |
Cancer Research Campaign Technology Limited |
O6-Helyettesített guaninszármazékok, ezeket tartalmazó gyógyászati készítmények, valamint eljárás e vegyületek előállítására
|
|
EP0795334B1
(de)
|
1996-03-12 |
2006-02-01 |
Sanofi-Aventis Deutschland GmbH |
Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen
|
|
WO1998011484A1
(fr)
|
1996-09-13 |
1998-03-19 |
Hitachi, Ltd. |
Processeur de commande a memoire d'historique
|
|
CA2278056C
(en)
|
1997-01-24 |
2006-12-12 |
Norsk Hydro Asa |
Gemcitabine derivatives
|
|
NZ330360A
(en)
|
1997-06-02 |
1999-03-29 |
Hoffmann La Roche |
5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
|
|
TW434252B
(en)
|
1997-07-23 |
2001-05-16 |
Univ Georgia Res Found |
Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine
|
|
JP4642226B2
(ja)
|
1998-02-06 |
2011-03-02 |
デ モントフォート ユニヴァーシティ |
ヒドロキシル化により活性化されたプロドラッグ
|
|
WO1999040944A2
(en)
|
1998-02-12 |
1999-08-19 |
De Montfort University |
Hydroxylation activated drug release
|
|
DE19834751A1
(de)
|
1998-08-01 |
2000-02-03 |
Boehringer Ingelheim Pharma |
Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
US6175001B1
(en)
|
1998-10-16 |
2001-01-16 |
The Scripps Research Institute |
Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same
|
|
KR100523119B1
(ko)
|
2000-03-16 |
2005-10-20 |
에프. 호프만-라 로슈 아게 |
Ｉｐ 길항제로서의 카복실산 유도체
|
|
GB0007401D0
(en)
|
2000-03-27 |
2000-05-17 |
Cancer Res Campaign Tech |
Substituted chalcones as therapeeutic compounds
|
|
US6875751B2
(en)
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
|
US7115585B2
(en)
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
JP3692927B2
(ja)
|
2000-11-07 |
2005-09-07 |
日本電気株式会社 |
ファクシミリ装置
|
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
|
CA2438737A1
(en)
|
2001-03-02 |
2002-09-12 |
F. Hoffmann-La Roche Ag |
Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
|
|
ATE302898T1
(de)
|
2001-05-18 |
2005-09-15 |
Hess Eng Inc |
Verfahren und vorrichtung zur herstellung eines katalysators
|
|
US6780859B2
(en)
|
2001-09-14 |
2004-08-24 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
|
EP1300403A1
(en)
|
2001-10-02 |
2003-04-09 |
Aventis Pharma S.A. |
Process for the manufacture of hypoxyxylerone derivatives
|
|
GB0123780D0
(en)
|
2001-10-03 |
2001-11-21 |
Cancer Res Ventures Ltd |
Substituted chalcones as therapeutic agents
|
|
GB0123777D0
(en)
|
2001-10-03 |
2001-11-21 |
Cancer Res Ventures Ltd |
Substituted chalcones as therapeutic agents
|
|
WO2004041203A2
(en)
|
2002-11-04 |
2004-05-21 |
Xenoport, Inc. |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
|
|
CN102174038A
(zh)
|
2003-02-19 |
2011-09-07 |
耶鲁大学 |
用于治疗病毒感染的抗病毒核苷
|
|
US7148226B2
(en)
|
2003-02-21 |
2006-12-12 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
|
CA2548513A1
(en)
|
2003-12-04 |
2005-07-07 |
Wyeth |
Biaryl sulfonamides and methods for using same
|
|
CA2550299C
(en)
|
2003-12-22 |
2010-03-30 |
Christopher R. Roberts |
Process for fluorocytidine derivatives
|
|
WO2005072061A2
(en)
|
2004-02-02 |
2005-08-11 |
Biosight Ltd. |
Conjugates for cancer therapy and diagnosis
|
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
GB0421294D0
(en)
|
2004-09-24 |
2004-10-27 |
Angiogene Pharm Ltd |
Bioreductively-activated prodrugs
|
|
CA2589850C
(en)
|
2004-12-17 |
2012-05-01 |
Eli Lilly And Company |
Amide prodrug of gemcitabine, compositions and use thereof
|
|
EP1676834A1
(en)
|
2004-12-30 |
2006-07-05 |
Sanofi-Aventis Deutschland GmbH |
Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
|
|
NO322682B1
(no)
|
2005-03-18 |
2006-11-27 |
Clavis Pharma Asa |
Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
|
|
EP1937658A1
(en)
|
2005-10-06 |
2008-07-02 |
Sanofi-Aventis |
4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
US20090069557A1
(en)
|
2006-02-06 |
2009-03-12 |
Dr. Reddy's Laboratories Ltd. |
Preparation of gemcitabine
|
|
US20080004237A1
(en)
|
2006-02-23 |
2008-01-03 |
Tam Joemy C |
Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers
|
|
US20070225248A1
(en)
|
2006-03-21 |
2007-09-27 |
Clavis Pharma As |
Oral dosage forms of gemcitabine derivatives
|
|
GB0722769D0
(en)
|
2007-11-21 |
2008-01-02 |
Biolipox Ab |
New compounds
|
|
EP2136626A4
(en)
|
2007-03-19 |
2011-02-23 |
Oregon State |
Mannich base n-oxide drugs
|
|
CN100475832C
(zh)
|
2007-05-31 |
2009-04-08 |
南京卡文迪许生物工程技术有限公司 |
一种新颖的高立体选择性合成吉西他滨工艺及中间体
|
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain Compounds, Compositions and Methods
|
|
KR20100102107A
(ko)
|
2007-11-06 |
2010-09-20 |
파마이센시아 코퍼레이션 |
β-뉴클레오시드의 새로운 합성 방법
|
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
|
WO2011017297A2
(en)
*
|
2009-08-03 |
2011-02-10 |
The University Of North Carolina At Chapel Hill |
Biodegradable delivery system complexes for the delivery of bioactive compounds
|
|
US20130131008A1
(en)
|
2011-10-25 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Lipophilic monophosphorylated derivatives and nanoparticles
|
|
CN104955458A
(zh)
|
2012-11-07 |
2015-09-30 |
Z·索 |
取代的吉西他滨芳基酰胺类似物和使用所述类似物的治疗方法
|
|
WO2014145207A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Ohio State Innovation Foundation |
Substituted gemcitabine bicyclic amide analogs and treatment methods using same
|
|
CN106459130A
(zh)
*
|
2014-03-03 |
2017-02-22 |
纽科利制药公司 |
吉西他滨类似物
|
|
CN105001291B
(zh)
|
2014-04-15 |
2018-12-04 |
上海知萌生物医药科技有限公司 |
吉西他滨化学传递前药及其制备方法和应用
|
|
CN105001191A
(zh)
*
|
2015-07-23 |
2015-10-28 |
广西师范学院 |
具有5,2’-二羟基-4’-甲氧基-3-香叶基黄酮骨架的衍生物及其制备方法和用途
|
|
CA3090272A1
(en)
*
|
2018-02-02 |
2019-08-08 |
Maverix Oncology, Inc. |
Novel small molecule drug conjugates of gemcitabine derivatives
|
|
AU2019216531A1
(en)
*
|
2018-02-02 |
2020-09-24 |
Maverix Oncology, Inc. |
Small molecule drug conjugates of gemcitabine monophosphate
|